title: Fatal erosive lichen planus.
authors.forename: N
authors.initials: N
authors.lastname: Sheth
authors.forename: R
authors.initials: R
authors.lastname: Bull
authors.forename: R
authors.initials: R
authors.lastname: Cerio
authors.forename: C
authors.initials: C
authors.lastname: Harwood
authors.forename: E
authors.initials: E
authors.lastname: O'Toole
authors.forename: D
authors.initials: D
authors.lastname: Paige
authors.forename: P
authors.initials: P
authors.lastname: Goldsmith
mesh_terms: D003879:Dermatologic Agents / Q000627:therapeutic use; D018450:Disease Progression; D000068800:Etanercept; D017809:Fatal Outcome; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D008010:Lichen Planus / Q000473:pathology* / Q000523:psychology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010554:Personality Disorders / Q000150:complications; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D016312:Treatment Refusal; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D003879:Dermatologic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept